Document Detail


The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.
MedLine Citation:
PMID:  17532044     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
For nearly as long as lithium has been in clinical use for the treatment of bipolar disorder, depression, and other conditions, investigators have attempted to characterize its effects on behaviors in rodents. Lithium consistently decreases exploratory activity, rearing, aggression, and amphetamine-induced hyperlocomotion; and it increases the sensitivity to pilocarpine-induced seizures, decreases immobility time in the forced swim test, and attenuates reserpine-induced hypolocomotion. Lithium also predictably induces conditioned taste aversion and alterations in circadian rhythms. The modulation of stereotypy, sensitization, and reward behavior are less consistent actions of the drug. These behavioral models may be relevant to human symptoms and to clinical endophenotypes. It is likely that the actions of lithium in a subset of these animal models are related to the therapeutic efficacy, as well the side effects, of the drug. We conclude with a brief discussion of various molecular mechanisms by which these lithium-sensitive behaviors may be mediated, and comment on the ways in which rat and mouse models can be used more effectively in the future to address persistent questions about the therapeutically relevant molecular actions of lithium.
Authors:
Kelley C O'Donnell; Todd D Gould
Related Documents :
2594874 - Behavioral performance and seizure activity of lithium-intoxicated sprague-dawley rats ...
3001884 - Reduction of specific arginine-vasopressin binding sites of renal medulla membranes in ...
2434594 - Sodium transport and the cellular sodium transport pool of colonic epithelium: effects ...
6253274 - Lithium-induced polyuria: effect of lithium on adenylate cyclase and adenosine 3',5'-mo...
12106034 - Effect of prior dopamine denervation on survival and fiber outgrowth from intrastriatal...
20734424 - Endogenous nitric oxide can act as beneficial or deleterious in the hypoxic lung depend...
Publication Detail:
Type:  Journal Article; Review     Date:  2007-04-13
Journal Detail:
Title:  Neuroscience and biobehavioral reviews     Volume:  31     ISSN:  0149-7634     ISO Abbreviation:  Neurosci Biobehav Rev     Publication Date:  2007  
Date Detail:
Created Date:  2007-08-27     Completed Date:  2007-11-21     Revised Date:  2010-09-16    
Medline Journal Info:
Nlm Unique ID:  7806090     Medline TA:  Neurosci Biobehav Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  932-62     Citation Subset:  IM    
Affiliation:
The Laboratory of Molecular Pathophysiology, Mood and Anxiety Disorders Program, National Institute of Mental Health, NIH, HHS, Bldg 35, Rm 1C-912, 35 Convent Drive, Bethesda, MD 20892 3711, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Behavior, Animal / drug effects*
Bipolar Disorder / drug therapy
Depressive Disorder / drug therapy
Disease Models, Animal
Humans
Lithium Compounds / pharmacology*,  therapeutic use
Mice
Mice, Inbred Strains
Rats
Rats, Inbred Strains
Species Specificity
Grant Support
ID/Acronym/Agency:
NIH0010875152//PHS HHS
Chemical
Reg. No./Substance:
0/Lithium Compounds
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization of the CD3zeta, CD3gammadelta and CD3epsilon subunits of the T cell receptor comple...
Next Document:  Current status of coastal zone issues and management in China: a review.